Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: A comparative study with amphetamine and diazepam

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 4, 2009, Pages 636-642

  Castro, A A ^a   Moretti, M ^a   Casagrande, T S ^a   Martinello, C ^a   Petronilho, F ^a   Steckert, A V ^a   Guerrini, R ^c   Calo', G ^b   Dal Pizzol, F ^a   Quevedo, J ^a   Gavioli, E C ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Neuroscience Center   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Amphetamine; Brain structures; Catalase; Diazepam; Lipid peroxidation; Locomotor activity; Neuropeptide S; Oxidative stress; Protein carbonyls; Superoxide dismutase

Indexed keywords

AMPHETAMINE; CATALASE; DIAZEPAM; LIPID PEROXIDASE; NEUROPEPTIDE S; PROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN DAMAGE; CEREBELLUM; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

AMPHETAMINE; ANIMALS; BRAIN CHEMISTRY; CATALASE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAZEPAM; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; LIPID PEROXIDATION; MALE; MICE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEUROPEPTIDES; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE;

EID: 58749094797     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.10.015     Document Type: Article

References (38)

1. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
2. Bannister J.V., and Calabrese L. Assays for superoxide dismutase. Methods Biochem Anal 32 (1987) 279-312
3. Beck B., Fernette B., and Stricker-Krongrad A. Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochem Biophys Res Commun 332 3 (2005) 859-865
4. Brown J.M., and Yamamoto B.K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 99 (2003) 45-53
5. Camarda V., Trapella C., Calo G., Guerrini R., Rizzi A., Ruzza C., et al. Synthesis and biological activity of human neuropeptide S analogues modified in position 2. J Med Chem 51 3 (2008) 655-658
6. Ciccocioppo R., Economidou D., Cannella N., Fedeli A., Cippitelli A., Calo G., et al. Inhibition of palatable food intake by neuropeptide S is reversed by its analogue [Ala3]hNPS (2006), Socienty for Neuroscience 809.807/O815
7. Ciccocioppo R., Kallupi M., Cannella N., Braconi S., Stopponi S., and Economidou D. Neuropeptide S system activation facilitates conditioned reinstatement of cocaine-seeking in the rat (2007), Society for Neuroscience 271.218/Z271
8. Cline M.A., Godlove D.C., Nandar W., Bowden C.N., and Prall B.C. Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus). Comp Biochem Physiol A Mol Integr Physiol 148 3 (2007) 657-663
9. Cline M.A., Prall B.C., Smith M.L., Calchary W.A., and Siegel P.B. Differential appetite-related responses to central neuropeptide S in lines of chickens divergently selected for low or high body weight. J Neuroendocrinol 20 7 (2008) 904-908
10. Dalle-Donne I., Aldini G., Carini M., Colombo R., Rossi R., and Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10 2 (2006) 389-406
11. Dotan Y., Lichtenberg D., and Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43 3 (2004) 200-227
12. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186 (1990) 407-421
13. Frey B.N., Martins M.R., Petronilho F.C., Dal-Pizzol F., Quevedo J., and Kapczinski F. Increased oxidative stress after repeated amphetamine exposure: possible relevance as an animal model of mania. Bipolar Disorders 8 (2006) 275-280
14. Frey B.N., Valvassori S.S., Réus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res 31 (2006) 699-703
15. Gavioli E.C., Rae G.A., Calo G., Guerrini R., and De Lima T.C.M. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Br J Pharmacol 136 (2002) 764-772
16. Gavioli E.C., Marzola G., Guerrini R., Bertorelli R., Zucchini S., De Lima T.C.M., et al. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci 17 (2003) 1987-1990
17. Kim D.H., Jung J.S., Song D.K., Suh H.W., Huh S.O., and Kim Y.H. Intracerebroventricular injection-induced increase in plasma corticosterone levels in the mouse: a stress model. J Pharmacol Toxicol Methods 39 2 (1998) 71-73
18. Laursen S.E., and Belhnap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16 4 (1986) 355-357
19. Leonard S.K., Dwyer J.M., Sukoff Rizzo S.J., Platt B., Logue S.F., Neal S.J., et al. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berl) 197 4 (2008) 601-611
20. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233 (1994) 346-357
21. Lotharius J., and O'Malley K.L. Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. Ann Neurol 49 1 (2001) 79-89
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
23. Quinton M.S., and Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 8 2 (2006) E337-347
24. Matés J.M., and Sánchez-Jiménez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4 (1999) D339-345
25. Meagher E.A., and FitzGerald G.A. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 28 12 (2000) 1745-1750
26. Musavi S., and Kakkar P. Diazepam induced early oxidative changes at the subcellular level in rat brain. Mol Cell Biochem 178 (1998) 41-46
27. Musavi S., and Kakkar P. Pro and antioxidant responses to repeated administration of diazepam in rat brain. Mol Cell Biochem 206 1-2 (2000) 97-103
28. Niimi M. Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats. Endocrine 30 1 (2006) 75-79
29. Paneda C., de Lecea L., and Roberts A.J. Neuropeptide S increases cocaine seeking behaviour. Society for Neuroscience (2007) 611.611/KK613, San Diego
30. Reinscheid R.K., Xu Y.L., and Civelli O. Neuropeptide S: a new player in the modulation of arousal and anxiety. Mol Interv 5 1 (2005) 42-46
31. Reinscheid R.K., Xu Y.L., Okamura N., Zeng J., Chung S., Pai R., et al. Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther 315 (2005) 1338-1345
32. Rizzi A., Vergura R., Marzola G., Ruzza C., Guerrini R., Salvadori S., et al. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 154 (2008) 471-479
33. Roth A.L., Marzola E., Rizzi A., Arduin M., Trapella C., Corti C., et al. Structure-activity studies on neuropeptide S - identification of the amino acid residues crucial for receptor activation. J Biol Chem 281 (2006) 30,20820809-30,20816
34. Smith K.L., Patterson M., Dhillo W.S., Patel S.R., Semjonous N.M., Gardiner J.V., et al. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 147 7 (2006) 3510-3518
35. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497
36. Xu Y.L., Gall C.M., Jackson V.R., Civelli O., and Reinscheid R.K. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S expressing neurons in the rat brain. J Comp Neurol 500 (2007) 84-102
37. Wenger G.R. The role of control activity levels in the reported strain differences to the behavioral effects of drugs in mice. Pharmacol Biochem Behav 32 1 (1989) 241-247
38. Yamamoto B.K., and Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 287 1 (1998) 107-114